Pediatrix Medical Group, Inc. (NYSE:MD) Receives Consensus Recommendation of “Hold” from Brokerages

Shares of Pediatrix Medical Group, Inc. (NYSE:MD) have received an average rating of “Hold” from the six brokerages that are currently covering the firm, MarketBeat.com reports. Five research analysts have rated the stock with a hold recommendation and one has given a buy recommendation to the company. The average 12 month price objective among brokers that have updated their coverage on the stock in the last year is $21.00.

A number of research firms have recently commented on MD. Weiss Ratings reissued a “hold (c+)” rating on shares of Pediatrix Medical Group in a report on Monday, December 29th. Zacks Research downgraded shares of Pediatrix Medical Group from a “strong-buy” rating to a “hold” rating in a research note on Friday, January 23rd. Truist Financial boosted their price target on Pediatrix Medical Group from $17.00 to $24.00 and gave the company a “hold” rating in a report on Monday, November 10th. Finally, UBS Group increased their price objective on shares of Pediatrix Medical Group from $16.50 to $23.00 and gave the company a “neutral” rating in a research report on Wednesday, November 5th.

Insider Activity at Pediatrix Medical Group

In other Pediatrix Medical Group news, Director Michael A. Rucker sold 10,478 shares of the company’s stock in a transaction on Monday, November 17th. The shares were sold at an average price of $23.00, for a total transaction of $240,994.00. Following the completion of the transaction, the director directly owned 59,101 shares in the company, valued at approximately $1,359,323. This represents a 15.06% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, CEO Mark S. Ordan sold 23,000 shares of the business’s stock in a transaction that occurred on Monday, December 15th. The stock was sold at an average price of $22.41, for a total value of $515,430.00. Following the sale, the chief executive officer owned 302,805 shares of the company’s stock, valued at $6,785,860.05. The trade was a 7.06% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. 0.90% of the stock is owned by corporate insiders.

Institutional Trading of Pediatrix Medical Group

A number of hedge funds and other institutional investors have recently made changes to their positions in MD. Smartleaf Asset Management LLC boosted its position in shares of Pediatrix Medical Group by 10.6% in the third quarter. Smartleaf Asset Management LLC now owns 6,250 shares of the company’s stock worth $101,000 after acquiring an additional 601 shares during the last quarter. PNC Financial Services Group Inc. raised its position in shares of Pediatrix Medical Group by 4.5% during the 3rd quarter. PNC Financial Services Group Inc. now owns 14,525 shares of the company’s stock valued at $243,000 after acquiring an additional 631 shares in the last quarter. Gotham Asset Management LLC raised its stake in Pediatrix Medical Group by 0.6% during the third quarter. Gotham Asset Management LLC now owns 116,093 shares of the company’s stock worth $1,945,000 after acquiring an additional 724 shares during the period. ProShare Advisors LLC lifted its holdings in shares of Pediatrix Medical Group by 4.6% in the 4th quarter. ProShare Advisors LLC now owns 16,816 shares of the company’s stock worth $360,000 after purchasing an additional 734 shares during the last quarter. Finally, Amalgamated Bank boosted its holdings in shares of Pediatrix Medical Group by 3.5% during the third quarter. Amalgamated Bank now owns 24,891 shares of the company’s stock valued at $417,000 after acquiring an additional 831 shares during the period. Institutional investors and hedge funds own 97.71% of the company’s stock.

Pediatrix Medical Group Stock Down 2.5%

Shares of MD traded down $0.55 during midday trading on Thursday, hitting $20.93. The stock had a trading volume of 78,725 shares, compared to its average volume of 528,275. The company has a 50 day simple moving average of $21.72 and a two-hundred day simple moving average of $19.19. Pediatrix Medical Group has a twelve month low of $11.84 and a twelve month high of $24.99. The firm has a market cap of $1.80 billion, a price-to-earnings ratio of 11.04 and a beta of 0.76. The company has a debt-to-equity ratio of 0.65, a current ratio of 1.83 and a quick ratio of 1.83.

About Pediatrix Medical Group

Pediatrix Medical Group, Inc (NYSE:MD) is a national physician-led medical group specializing in high-acuity newborn, maternal-fetal and pediatric subspecialty care. Headquartered in Sunrise, Florida, the company delivers clinical services through hospital-based physician staffing, advanced practitioner support and telemedicine programs. Its core specialties include neonatology, maternal-fetal medicine, pediatric cardiology, pediatric critical care, pediatric emergency medicine and anesthesiology.

Founded in 1979 and formerly known as MEDNAX, the company rebranded as Pediatrix Medical Group in 2022 to align its corporate identity with its primary clinical offerings.